USFDA completes inspection at Strides Pharma Science’s Bangalore facility

05 Nov 2018 Evaluate

Strides Pharma Science’s formulations facility in Bangalore has underwent a US Food and Drug Administration (USFDA) inspection that ended on November 02, 2018. The inspection was completed successfully with Zero 483 observations.

The facility (KRS Gardens) in Bangalore is the largest facility for the company and has capability in several dosage formats including tablets, capsules (both hard gelatin and soft gelatin), ointments, creams and liquids. The facility supports several important current and future submissions for the US Market.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

896.80 -1.20 (-0.13%)
03-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1508.40
Dr. Reddys Lab 6332.85
Cipla 1424.40
Zydus Lifesciences 992.00
Lupin 1663.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.